Clinical evaluation of weekly 1-hour infusion of paclitaxel in patients with hormone-refractory prostate cancer

被引:0
|
作者
Hussain, M
机构
[1] Wayne State Univ, Detroit, MI USA
[2] Karmanos Canc Inst, Detroit, MI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:138 / 138
页数:1
相关论文
共 50 条
  • [41] Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer
    Matsumoto, Akihiro
    Inoue, Atsushi
    Yokoi, Satoshi
    Nozumi, Kazuyoshi
    Miyazaki, Kanetaka
    Hosoki, Shigeru
    Nagata, Maki
    Yamaguchi, Kunio
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (08) : 687 - 691
  • [42] Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer
    Garcia, Jorge A.
    Rosenberg, Jonathan E.
    Weinberg, Vivian
    Scott, Janet
    Frohlich, Mark
    Park, John W.
    Small, Eric J.
    BJU INTERNATIONAL, 2007, 99 (03) : 519 - 524
  • [43] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [44] Management of hormone-refractory prostate cancer
    Dogliotti, L
    Mosca, A
    TUMORI, 2003, : S147 - S149
  • [45] Taxanes in hormone-refractory prostate cancer
    Kang, MH
    Figg, WD
    Dahut, W
    CANCER PRACTICE, 1999, 7 (05) : 270 - 272
  • [46] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [47] Satraplatin for hormone-refractory prostate cancer
    Kerr, Cathel
    LANCET ONCOLOGY, 2007, 8 (04): : 290 - 290
  • [48] Chemotherapy for hormone-refractory prostate cancer
    Shelley, Mike
    Harrison, Craig
    Coles, Bernadette
    Staffurth, John
    Wilt, Timothy J.
    Mason, Malcolm D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [49] Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients
    Berruti, A
    Mosca, A
    Bitossi, R
    Gorzegno, G
    Guercio, S
    Poggio, M
    Tampellini, M
    Porpiglia, F
    Ostellino, O
    Scarpa, RM
    Dogliotti, L
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4475 - 4479
  • [50] Weekly 1-hour paclitaxel as first line chemotherapy for advanced and metastatic breast cancer
    Wist, EA
    Sommer, HH
    Oestenstad, B
    Risberg, T
    Fjaestad, K
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 138 - 138